Slate Path Capital LP Teva Pharmaceutical Industries LTD Transaction History
Slate Path Capital LP
- $5.19 Billion
- Q4 2024
A detailed history of Slate Path Capital LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Slate Path Capital LP holds 8,491,033 shares of TEVA stock, worth $135 Million. This represents 3.6% of its overall portfolio holdings.
Number of Shares
8,491,033
Previous 13,668,233
37.88%
Holding current value
$135 Million
Previous $246 Million
24.02%
% of portfolio
3.6%
Previous 3.89%
Shares
7 transactions
Others Institutions Holding TEVA
# of Institutions
677Shares Held
578MCall Options Held
25.5MPut Options Held
14.7M-
Black Rock Inc. New York, NY43MShares$684 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$620 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.7MShares$583 Million48.01% of portfolio
-
Menora Mivtachim Holdings Ltd.28.4MShares$451 Million3.94% of portfolio
-
Exor Capital LLP London, X027.2MShares$432 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $17.7B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...